Safety, Efficacy, and Tolerability of Memantine for Cognitive and Adaptive Outcome Measures in Adolescents and Young Adults with Down Syndrome: a Randomised, Double-Blind, Placebo-Controlled Phase 2 Trial.Alberto C. S. Costa,Ana C. Brandao,Richard Boada,Veridiana L. Barrionuevo,Hudson G. Taylor,Elizabeth Roth,Melissa R. Stasko,Mark W. Johnson, Fernanda F. Assir, Maria P. Roberto, Patricia Salmona, Guilherme Abreu-Silveira,Ilya Bederman,Erin Prendergast,Anke Huls,Sarina Abrishamcar,Zan Mustacchi,Thomas Scheidemantel,Nancy J. Roizen,Stephen RuedrichThe Lancet Neurology(2021)引用 15|浏览26AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要